AZN Description — AstraZeneca Plc

AstraZeneca is a holding company. Through its subsidiaries, Co. is engaged in biopharmaceutical business. Co. focuses on three main therapy areas: oncology - aims to change the practice of medicine and transform the lives of patients living with cancer; cardiovascular, renal & metabolism includes treatment of four interrelated conditions - cardiovascular disease, heart failure, metabolic and renal diseases; and respiratory and immunology - aims to transform the treatment of asthma and COPD by eliminating preventable asthma attacks across disease severities and removing COPD as a cause of death through earlier, biology-led treatment.

Company Name: 
AstraZeneca Plc
Drugs & Pharmaceuticals
Number of ETFs Holding AZN: 
Total Market Value Held by ETFs: 
Total Market Capitalization: 
% of Market Cap. Held by ETFs: 
 ETF   AZN Weight   AZN Amount 
 FVD   0.49%   $58,620,504         
 IXJ   1.02%   $35,412,427         
 FPX   1.18%   $24,524,324         
 PPH   5.61%   $18,377,137         
 QQQJ   1.17%   $14,150,708         
 BIB   1.28%   $3,992,153         
 URTH   0.12%   $1,951,289         
 IBBQ   1.58%   $831,393         
 SPGM   0.08%   $482,164         
 IEIH   1.16%   $481,324         
List of all 14 ETFs holding AZN »
Quotes delayed 20 minutes

Strong Buy (3.75 out of 4)
66th percentile
(ranked higher than approx. 66% of all stocks covered)

Analysts Forecast:
AZN Price Target

Based on data provided by Zacks Investment Research via

ETFs Holding AZN | AstraZeneca Plc | ETF Channel |

Copyright © 2010 - 2021, All Rights Reserved Nothing in ETF Channel is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and ETF videos powered by Market News Video. Quote data delayed at least 20 minutes; data powered by Ticker Technologies, and Mergent. Contact ETF Channel; Meet Our Editorial Staff.